News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<Research>Citi Upbeat on Microsoft (MSFT.US) Leading Position in GenAI, Reiterates Rating Buy
It is reported that Microsoft (MSFT.US) planned to cut 3% of its global workforce, affecting approx. 6,000 employees. Citi Research issued a research report estimating that the res...
Reset
Send
The window will close in 5 seconds
<Research>Citi Upbeat on Microsoft (MSFT.US) Leading Position in GenAI, Reiterates Rating Buy
Close
Recommend
3
Positive
3
Negative
4
 
SHORT SELL
 
STOCK INFO

It is reported that Microsoft (MSFT.US)      planned to cut 3% of its global workforce, affecting approx. 6,000 employees.

Citi Research issued a research report estimating that the restructuring costs this time will be between US$760 million and US$800 million, referencing the Company's 2023 layoff of 10,000 employees which resulted in related expenses of US$1.2 billion.

Related NewsCore Producer Prices MoM for April in the United States is -0.4%, lower than the previous value of 0.4%. The forecast was 0.3%.
The broker believed that this reflects Microsoft's cautious approach to enhancing operational efficiency, with some of the savings expected to be reinvested in R&D, including supporting AI product development.

Based on the 3FQ25 results and management's statements, Citi Research remained confident on market demand, and was optimistic about Microsoft's leading position in the GenAI field. The broker reiterated rating at Buy, and elevated its target price from US$480 to US$540, with expectations that Microsoft can continue to post double-digit profit growth.
(Real-time Streaming US Stocks Quote; Except All OTC quotes are at least 15 minutes delayed.)

AASTOCKS Financial News
Website: www.aastocks.com
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.